# FDA Inspection 1080814 - Daiichi Sankyo Chemical Pharma Co., Ltd. - January 18, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/daiichi-sankyo-chemical-pharma-co-ltd/0b7bde6c-6425-4ca6-a6c9-747e82f47a45/
Source feed: FDA_Inspections

> FDA Inspection 1080814 for Daiichi Sankyo Chemical Pharma Co., Ltd. on January 18, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1080814
- Company Name: Daiichi Sankyo Chemical Pharma Co., Ltd.
- Inspection Date: 2019-01-18
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1226353 - 2023-12-22](https://www.globalkeysolutions.net/api/records/fda_inspections/daiichi-sankyo-chemical-pharma-co-ltd/56a2c626-2e61-41ea-b358-8e6ed18c4d79/)
- [FDA Inspection 934436 - 2015-07-02](https://www.globalkeysolutions.net/api/records/fda_inspections/daiichi-sankyo-chemical-pharma-co-ltd/3af3e032-9da4-413f-a751-90585b7a0475/)

Company: https://www.globalkeysolutions.net/companies/daiichi-sankyo-chemical-pharma-co-ltd/846f1b3f-281e-4616-ae05-902bf9bcb28c

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c